Implants
are used to treat orthopedic, dental and spinal injuries. In many
medical conditions, such as injuries and trauma, bone grafts are used to
stimulate the growth of new bone which supports implants. Most bone
grafts materials are derived from human and animal bones.
In
addition, bone grafting is a surgical procedure which is used to fix
problems associated with joints or bones. Bone grafting and
transplanting of joint tissue plays a vital role in fixing of bones
after injuries and trauma. The bone used in a bone graft can come from
patient’s own body, from a donor, or could be entirely manmade. Bone
grafts are mainly classified into two types: allograft and autograft. In
allograft, graft uses bone from a donor or a cadaver that has been
stored in tissue banks. However, autograft is defined as those types of
grafts which are made from a bone inside patient body such as hips and
ribs. The use of bone grafts depend on the types of injuries and
diseases. For instance, allograft is mainly used in the treatment of
knee, hip, arms and legs injuries.
The global bone grafts market
is segmented into standard allografts, demineralized bone matrix (DBM),
machined bone allografts, bone morphogenetic protein (BMP), synthetic
bone grafts and stem cell based bone grafts.
A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/3836
In
terms of geographic, North America dominates the global bone grafts
market. This is due to increased awareness about importance of bone
grafting procedures in the region. In addition, increased adoption of
cell-based matrices is also supporting in the growth of bone grafts
market in the region. The U.S. represents the largest market for bone
grafts followed by Canada in North America. In Europe, Germany, Italy,
the U.K. and France holds major share of bone grafts market. However,
Asia is expected to show high growth rates in the next five years in
global bone grafts market. This is due to increasing public awareness
towards bone regeneration in the region. Japan, China and India are
expected to be the fastest growing bone grafts markets in Asia.
In
recent time, rising number of aging populations is key driver of the
global bone grafts market. Increasing number of spinal fusion and joint
reconstruction surgeries, along with advanced bone grafts and increased
public awareness of bone regeneration achieved through biologics are
also supporting in the growth of global bone grafts market. Moreover,
rising prevalence of periodontal diseases coupled with increasing
incidences of dental fractures have fueled the demand of dental bone
grafts market.
To view TOC of this report is available upon request @ https://www.persistencemarketresearch.com/toc/3836
However,
stringent regulations obstruct the growth of bone grafts market. In
addition, high cost of bone grafting surgeries and inadequate
reimbursement policies for bone grafting also hampers the growth of
global bone grafts market. Rapid product launches and increasing mergers
and acquisitions between bone graft systems manufacturing companies are
some of the major trends in the global bone grafts market.
Some
of the major companies operating in the global bone grafts market are
Zimmer Holdings, Inc., BioMimetic Therapeutics LLC, Wright Medical
Technology, Inc., Stryker Corporation, Smith & Nephew Plc, RTI
Surgical, Inc., Olympus Biotech Corporation, NuVasive, Inc., NovaBone
Products LLC, Medtronic, Inc., LifeNet Health, Inc., Integra
LifeSciences Holdings Corporation, Exactech, Inc., DePuy Spine, Inc.,
Synthes Inc., DePuy Synthes Companies, Biomet, Inc. and AlloSource.
No comments:
Post a Comment